- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.87 BnMarket Estimate, 2026
$0.93 BnMarket Forecast, 2034
$1.65 BnCAGR, 2026–2034
7.43%Executive Summary: Middle East and Africa Enteral Feeding Formulas Market
- Market Scope: Comprehensive regional analysis of the Middle East and Africa enteral feeding formulas sector, detailing product formulations, patient stages, clinical applications, healthcare end-users, and country-level profiles across the forecast period 2026-2034.
- Market Valuation: Valued at USD 0.87 billion in 2025, reaching USD 0.93 billion in 2026, and projected to expand to USD 1.65 billion by 2034, growing at a CAGR of 7.43% from 2026 to 2034.
- Primary Growth Drivers: Increased prevalence of chronic diseases and disorders in MEA, rising preterm birth rates, expanding home health agencies and nursing homes, and cost advantages of enteral over parenteral nutrition.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product | Polymeric Formulas (held dominant market share, widely used for patients with normal gastrointestinal function) | Disease-Specific Formulas (projected for high growth driven by customized nutritional management for renal, hepatic, and diabetic care) |
| By Stage | Adults (accounted for the largest share anchored by rising geriatric populations and chronic lifestyle disorders) | Pediatrics (high-growth segment propelled by increasing neonatal intensive care needs and management of preterm births) |
| By Application | Neurology & Oncology (captured major market shares supported by stroke, neurodegenerative disorders, and cancer cachexia therapies) | Gastroenterology (expanding rapidly via targeted nutritional support and post-surgical recovery pathways) |
| By End User | Hospitals (dominated revenue generation backed by acute care settings and surgical recovery units) | Home Care (fastest-growing segment fueled by rising demand for home health agencies, nursing homes, and long-term care facilities) |
| By Country | UAE & KSA (market leaders playing a significant role in regional adoption backed by advanced healthcare infrastructure) | South Africa & Rest of GCC (key emerging regional hubs driven by expanding healthcare expenditure and modernizing facilities) |
Major Market Players & Industry Landscape
Market Structure: Competitive regional landscape featuring global nutritional and pharmaceutical leaders expanding distribution networks, clinical support services, and specialized enteral feeding product lines across the Middle East and Africa.
Key Companies: Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Hormel Foods, LLC, Victus Inc., Meiji Holdings Co., Ltd., and Global Health Product Inc.
Download Free Sample Report
Middle East and Africa Enteral Feeding Formulas Market Size
The Middle East and Africa enteral feeding devices market size was valued at USD 0.87 billion in 2025 and is anticipated to reach USD 0.93 billion in 2026 from USD 1.65 billion by 2034, growing at a CAGR of 7.43% during the forecast period from 2026 to 2034.
The increased prevalence of chronic diseases and disorders in MEA is one of the key factors driving enteral feeding formulas. In addition, the rising number of preterm births and the number of home health agencies and nursing homes are increasing the demand for facilities that help patients recover from surgery.
The Middle East and Africa are projected to provide market participants with substantial growth prospects during the forecast period. This is owing to the countries' various healthcare markets, the rising prevalence of infectious and chronic diseases, and more outstanding R&D efforts to develop breakthrough medical technology.
Furthermore, population growth, healthcare infrastructure development, increasing healthcare expenditure, and an increase in the senior population benefit the enteral feeding formulae market. Moreover, the surge in demand for customized medication creates profitable prospects for market players from 2026 to 2034.
Enteral nutrition is a convenient and cost-effective way to provide therapeutic nourishment to patients. However, there are a few disadvantages to employing these devices, including increased healthcare costs. Most enteral feeding problems are minor, but a few can be rather severe. Enteral nutrition metabolic issues are similar to those that emerge with parenteral nutrition, despite their lower prevalence and severity. Careful monitoring can help to reduce or prevent these problems. However, these concerns and the risk of death connected with these issues act as a deterrent to the widespread adoption of enteral feeding devices.
The Middle East and Africa enteral feeding formulas market had a moderate proportion of the global market in 2020, with the UAE and Kuwait playing a significant role in the MEA enteral feeding formulas market. However, increased demand for home care and an increase in chronic illness occurrences such as multiple sclerosis, obstructive pulmonary disease (COPD), stroke, chronic liver disease, and diabetes have altered the market in regional countries.
The gastrointestinal tract, which includes the esophagus, stomach, small and large intestines, provides artificial nutrition or medication to the organs. On the other hand, Parenteral feeding entails placing a catheter into the central or peripheral veins and delivering nutrients or medication directly into the bloodstream.
In addition, enteral nutrition is less expensive than parenteral nutrition. The average daily cost of enteral nutrition is roughly 40% cheaper than that of parenteral nourishment for a patient. Enteral feeding is currently commonly employed in several treatment regimens due to these benefits.
Furthermore, improvements in healthcare infrastructure, rising healthcare expenditures, and the expanding low-cost manufacturing advantage of MEA countries are expected to tempt market participants to invest in the region during the forecast period.
KEY MARKET PLAYERS
A few of the companies playing an influential role in the MEA Enteral Feeding Formulas Market profiled in the report are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).
MARKET SEGMENTATION
This research report on the Middle East and Africa enteral feeding formulas market has been segmented and sub-segmented into the following categories:
By Product
- Polymeric
- Monomeric
- Disease-Specific Formulas
By Stage
- Adults
- Pediatrics
By Application
- Oncology
- Gastroenterology
- Neurology
By End User
- Hospitals
- LTCS
- Home Care
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA